NM_013275.6:c.4344T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_013275.6(ANKRD11):​c.4344T>C​(p.Tyr1448Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0325 in 1,614,018 control chromosomes in the GnomAD database, including 987 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 70 hom., cov: 32)
Exomes 𝑓: 0.033 ( 917 hom. )

Consequence

ANKRD11
NM_013275.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.91

Publications

7 publications found
Variant links:
Genes affected
ANKRD11 (HGNC:21316): (ankyrin repeat domain containing 11) This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
ANKRD11 Gene-Disease associations (from GenCC):
  • KBG syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, Illumina, ClinGen
  • congenital heart defects, multiple types
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 16-89282198-A-G is Benign according to our data. Variant chr16-89282198-A-G is described in ClinVar as [Benign]. Clinvar id is 585411.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0248 (3770/152138) while in subpopulation NFE AF = 0.038 (2586/67996). AF 95% confidence interval is 0.0368. There are 70 homozygotes in GnomAd4. There are 1785 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3770 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD11NM_013275.6 linkc.4344T>C p.Tyr1448Tyr synonymous_variant Exon 9 of 13 ENST00000301030.10 NP_037407.4 Q6UB99
ANKRD11NM_001256182.2 linkc.4344T>C p.Tyr1448Tyr synonymous_variant Exon 10 of 14 NP_001243111.1 Q6UB99
ANKRD11NM_001256183.2 linkc.4344T>C p.Tyr1448Tyr synonymous_variant Exon 9 of 13 NP_001243112.1 Q6UB99

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD11ENST00000301030.10 linkc.4344T>C p.Tyr1448Tyr synonymous_variant Exon 9 of 13 5 NM_013275.6 ENSP00000301030.4 Q6UB99

Frequencies

GnomAD3 genomes
AF:
0.0248
AC:
3773
AN:
152020
Hom.:
70
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00696
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0238
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0158
Gnomad FIN
AF:
0.0267
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0380
Gnomad OTH
AF:
0.0325
GnomAD2 exomes
AF:
0.0277
AC:
6967
AN:
251428
AF XY:
0.0283
show subpopulations
Gnomad AFR exome
AF:
0.00671
Gnomad AMR exome
AF:
0.0197
Gnomad ASJ exome
AF:
0.0254
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.0281
Gnomad NFE exome
AF:
0.0399
Gnomad OTH exome
AF:
0.0309
GnomAD4 exome
AF:
0.0333
AC:
48734
AN:
1461880
Hom.:
917
Cov.:
36
AF XY:
0.0330
AC XY:
24004
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00618
AC:
207
AN:
33480
American (AMR)
AF:
0.0199
AC:
888
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0241
AC:
630
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0187
AC:
1616
AN:
86258
European-Finnish (FIN)
AF:
0.0289
AC:
1542
AN:
53416
Middle Eastern (MID)
AF:
0.0414
AC:
239
AN:
5766
European-Non Finnish (NFE)
AF:
0.0377
AC:
41924
AN:
1112004
Other (OTH)
AF:
0.0279
AC:
1684
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3191
6382
9574
12765
15956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1504
3008
4512
6016
7520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0248
AC:
3770
AN:
152138
Hom.:
70
Cov.:
32
AF XY:
0.0240
AC XY:
1785
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00694
AC:
288
AN:
41492
American (AMR)
AF:
0.0236
AC:
361
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3468
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.0162
AC:
78
AN:
4818
European-Finnish (FIN)
AF:
0.0267
AC:
283
AN:
10594
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0380
AC:
2586
AN:
67996
Other (OTH)
AF:
0.0322
AC:
68
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
180
360
539
719
899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0311
Hom.:
33
Bravo
AF:
0.0240
Asia WGS
AF:
0.00751
AC:
27
AN:
3478
EpiCase
AF:
0.0374
EpiControl
AF:
0.0402

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 01, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KBG syndrome Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 13, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.020
DANN
Benign
0.13
PhyloP100
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61744778; hg19: chr16-89348606; API